abstract |
The present invention relates to a family of phenyl-prenyl-ether derivatives of the following formula (I) and their use in the treatment of cognitive, neurodegenerative or neurological diseases or disorders such as Alzheimer's disease or Parkinson's disease. The invention also relates to pharmaceutical compositions comprising those compounds. Furthermore, the present invention is directed to the use of said compounds in the manufacture of a medicament for the treatment and / or prevention of cognitive, neurodegenerative or neurological diseases or disorders. |